Chicago ENT / Chicago Sleep Center accelerates patient outcomes, reduces overhead with EnsoHST
In 2024, Chicago ENT/Chicago Sleep Center (CENT/CSC) explored EnsoHST, an FDA-cleared, multi-night AI-powered home sleep testing solution that leverages data from pulse oximeters, to streamline the home testing process, reduce device costs, and expedite patient outcomes. Explore CENT/CSC’s rapid and efficient adoption and the significant benefits of adding affordable devices and cutting edge AI.